Particulate contamination describes the unintended presence of extraneous, mobile and undissolved particles in a parenteral solution [1;2].
These particles can be of various size, defining them as detectable by visual inspection (in general ≥ 50 µm) sub-visible inspection with a range of 2-50 µm in size in general.
Especially the sub-visible sized particles demand specific analytical tests for their detection.
With this external link You are about to leave this website. B. Braun does not own or control the content or the website you are about to open.
1 Werner PB, Winter G. (2015) Particle contamination of parenteralia and in-line filtration of proteinaceous drugs. Int J Pharm: S0378-5173(15)30349-5. doi: 10.1016/j.ijpharm.2015.10.082. [Epub ahead of print]
2 Doessegger L, Mahler HC, Szczesny P, Rockstroh H, Kallmeyer G, Langenkamp A, Herrmann J, Famulare J. (2012) The potential clinical relevance of visible particles in parenteral drugs. J Pharm Sci; 101(8): 2635-44
To read the abstract go to the literature page.
Not all products are registered and approved for sale in all countries or regions. Indications of use may also vary by country and region. Product images are for reference only. Please contact your country representative for product availability and information.